CGRP is essential for protection against alveolar epithelial cell necroptosis by activating the AMPK/L‐OPA1 signaling pathway during acute lung injury
Journal of Cellular Physiology · 2024
DOI: 10.1002/jcp.31169 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular Physiology, 2024. Verfasst von Hui-Ling Jiang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Immunotherapy Laboratory, College of Pharmacology, Southwest Minzu University, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Acute Lung Injury. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Health Commission Fund of Hunan Province, Southwest Minzu University Research Startup Funds.
Abstract (Originalsprache)
Alveolar epithelial cell (AEC) necroptosis is critical to disrupt the alveolar barrier and provoke acute lung injury (ALI). Here, we define calcitonin gene‐related peptide (CGRP), the most abundant endogenous neuropeptide in the lung, as a novel modulator of AEC necroptosis in lipopolysaccharide (LPS)‐induced ALI. Upon LPS‐induced ALI, overexpression of Cgrp significantly mitigates the inflammatory response, alleviates lung tissue damage, and decreases AEC necroptosis. Similarly, CGRP alleviated AEC necroptosis under the LPS challenge in vitro. Previously, we identified that long optic atrophy 1 (L‐OPA1) deficiency mediates mitochondrial fragmentation, leading to AEC necroptosis. In this study, we discovered that CGRP positively regulated mitochondrial fusion through stabilizing L‐OPA1. Mechanistically, we elucidate that CGRP activates AMP‐activated protein kinase (AMPK). Furthermore, the blockade of AMPK compromised the protective effect of CGRP against AEC necroptosis following the LPS challenge. Our study suggests that CRGP‐mediated activation of the AMPK/L‐OPA1 axis may have potent therapeutic benefits for patients with ALI or other diseases with necroptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immunotherapy Laboratory, College of Pharmacology, Southwest Minzu University, Chengdu, Sichuan, China.
- Department of Physiology, School of Basic Medical Science, Central South University, Changsha, Hunan, China.
- National Experimental Teaching Demonstration Center for Medical Function, Changsha, Hunan, China.
- Department of Geriatrics, Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China.
- Phase I Clinical Research Center, Xiangya Hospital, Central South University, Changsha, China.
- Department of Physiology, Hunan University of Medicine, Huaihua, Hunan, China.
ORCID-Profile: Hui-Ling Jiang, Yong Zhou, Cha-Xiang Guan
Förderung
- National Natural Science Foundation of China
- Health Commission Fund of Hunan Province
- Southwest Minzu University Research Startup Funds
Zitieren
APA
Jiang, H. L., Yang, H. H., Liu, Y. B., Duan, J. X., Guan, X. X., Zhang, C. Y., Zhong, W. J., Jin, L., Li, D., Li, Q., Zhou, Y., & Guan, C. X. (2024). CGRP is essential for protection against alveolar epithelial cell necroptosis by activating the AMPK/L‐OPA1 signaling pathway during acute lung injury. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.31169
Vancouver
Jiang HL, Yang HH, Liu YB, Duan JX, Guan XX, Zhang CY, et al. CGRP is essential for protection against alveolar epithelial cell necroptosis by activating the AMPK/L‐OPA1 signaling pathway during acute lung injury. Journal of Cellular Physiology. 2024. doi:10.1002/jcp.31169
BibTeX
@article{Jiang2024,
author = {Jiang, Hui-Ling and Yang, Hui-Hui and Liu, Yu-Biao and Duan, Jia-Xi and Guan, Xin-Xin and Zhang, Chen-Yu and Zhong, Wen-Jing and Jin, Ling and Li, Dai and Li, Qing and Zhou, Yong and Guan, Cha-Xiang},
title = {CGRP is essential for protection against alveolar epithelial cell necroptosis by activating the AMPK/L‐OPA1 signaling pathway during acute lung injury},
journal = {Journal of Cellular Physiology},
year = {2024},
doi = {10.1002/jcp.31169}
}
EUVIMED